Advisory Boards

The Industry Advisory Board (IAB) serves to ensure that the EDITH project will take into account the needs and requirements of European innovators to deliver products and services that benefit citizens and patients.
Members of the IAB meet periodically for discussions with experts from the EDITH consortium to review its developments and services, and to provide input and feedback.
The IAB was constituted in December 2022 and will serve for the duration of the project.
The members of the IAB represent the following companies and industry associations:

• Agoria (Belgium)
• Ansys
• Avicenna Alliance
• Bitkom (Germany)
• Dassault Systèmes
• DIGITALEUROPE
• Edwards Lifesciences
• ELEM Biotech
• Insilicare
• InSilicoTrials
• Johnson & Johnson
• Mediolanum Cardio Research (CRO)
• Novadiscovery
• Optum / UnitedHealth
• Philips
• Roche
• Siemens Healthineers
• Twinsight
• Virtonomy
• Voisin Consulting Life Sciences

The Advisory Group of Stakeholders (AGS) is a high-level advisory board representing the different stakeholders of the VHT. The AGS is an important component for strengthening the VHT ecosystem, providing high-level feedback and validation, and supporting its further development going forward. The AGS members informed input to the VHT Roadmap, elaborated by the EDITH consortium and the wider ecosystem through public activities onsite and online, and the AGS activities carry an important weight in the roadmap’s validation, wide dissemination, and acceptance. AGS members also discussed orientations for future research beyond the EDITH CSA and ongoing initiatives. The AGS is composed of high level experts from academia, clinics, industry (large companies and start-ups), trade associations, regulatory agencies and notified bodies. The expertise of the AGS members covers the technological, ethical, legal and social (ELSI) aspects related to VHT.